PolyPid Ltd. (NASDAQ: PYPD) announced that the European Medicines Agency has validated the company's Marketing Authorization Application for D-PLEX100, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE